The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics from clinical trial design, alternative payment models, scale-up and supply chain platforms for advanced therapies.
Alternative IPO Strategies for Cell and Gene Therapy Companies
On Demand – Monday, October 12, 2020
Cooley partner Yvan-Claude Pierre is a featured speaker.
This session will center on special purpose acquisition companies (SPACs), a space heating up within the biotech world. As of August 2020, 10 biotech-focused SPACs have been successful at raising capital with many others coming down the pike. The purpose of the panel is to understand why all these biotech-focused firms are getting involved in the space, what cell and gene therapy companies need to know about this alternative to a traditional IPO if approached, and what seasoned executives of public companies should know about potentially sponsoring their own biotech focused SPAC.
For more information or to receive the Cooley discount code, please email Tess Pascual.